MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhang, Ying ^a   Li, Tao ^b   Guo, Pengbo ^a   Kang, Jia ^a   Wei, Qing ^a   Jia, Xiaoqing ^c   Zhao, Wei ^a   Huai, Wanwan ^a   Qiu, Yumin ^a   Sun, Lei ^a   Han, Lihui ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CTNNBIP1 PROTEIN, HUMAN; MICRORNA; MIRN424 MICRORNA, HUMAN; SIGNAL PEPTIDE;

ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DISEASE COURSE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEPG2 CELL LINE; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED;

EID: 84906860991     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06248     Document Type: Article

References (40)

1. Simpson, C. D., Anyiwe, K. & Schimmer, A. D. Anoikis resistance and tumor metastasis. Cancer Lett 272, 177-185 (2008).
2. Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature reviews. Cancer 9, 265-273 (2009).
3. Zeisberg,M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-1437 (2009).
4. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428 (2009).
5. Bandres, E., Agirre, X., Ramirez, N., Zarate, R. & Garcia-Foncillas, J. MicroRNAs as cancer players: potential clinical and biological effects. DNA and cell biology 26, 273-282 (2007). (Pubitemid 46799176)
6. Schoof, C. R., Botelho, E. L., Izzotti, A. & Vasques Ldos, R. MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2, 414-433 (2012).
7. Kong, Y. W., Ferland-McCollough, D., Jackson, T. J. & Bushell, M. microRNAs in cancer management. Lancet Oncol 13, e249-258 (2012).
8. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature cell biology 10, 593-601 (2008). (Pubitemid 351627379)
9. Cao, L. et al. Involvement of anoikis-resistance in the metastasis of hepatoma cells. Exp Cell Res 315, 1148-1156 (2009).
10. Zhang, Z. et al. Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells. Cancer Lett 267, 106-115 (2008).
11. Chen, Y. C. et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PloS one 3, e2637 (2008).
12. Long, X. H. et al. Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med 5, 1048-1052 (2013).
13. Xu, J. et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32, 976-987 (2013).
14. Faraoni, I. et al. MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status. J Hematol Oncol 5, 26 (2012).
15. Miranda, K. C. et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217 (2006). (Pubitemid 44380294)
16. J. & Gumbiner, B. M. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. Am J Physiol Cell Physiol 286, C747-756 (2004). (Pubitemid 38543802)
17. Graham, T. A., Clements, W. K., Kimelman, D. & Xu, W. The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT. Mol Cell 10, 563-571 (2002). (Pubitemid 35284174)
18. Koyama, T. et al. Mutation and expression of the beta-catenin-interacting protein ICAT in human colorectal tumors. Jpn J Clin Oncol 32, 358-362 (2002). (Pubitemid 43102789)
19. Wu,W. K. et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29, 5761-5771 (2010).
20. Chen, X. et al. Characterization ofmicroRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997-1006 (2008).
21. Luanpitpong, S., Iyer, A. K., Azad, N., Wang, L. & Rojanasakul, Y. Nitrosothiol Signaling in Anoikis Resistance and Cancer Metastasis. For Immunopathol Dis Therap 3, 141-154 (2012).
22. Frisch, S. M., Schaller,M. & Cieply, B. Mechanisms that link the oncogenic epithelialmesenchymal transition to suppression of anoikis. J Cell Sci 126, 21-29 (2013).
23. Chamorro-Jorganes, A. et al. MicroRNA-16 and microRNA-424 regulate cellautonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31, 2595-2606 (2011).
24. Ghosh, G. et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 120, 4141-4154 (2010).
25. Llobet-Navas, D. et al. The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev 28, 765-782 (2014).
26. Zhao, H. et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke 44, 1706-1713 (2013).
27. Rosa, A. et al. The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci U S A 104, 19849-19854 (2007).
28. Oishi, T. et al. Osteogenic differentiation capacity of human skeletal musclederived progenitor cells. PLoS One 8, e56641 (2013).
29. Kim, J. et al. An endothelial apelin-FGF link mediated by miR-424 andmiR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19, 74-82 (2013).
30. Cui, L. et al. A set of microRNAs mediate direct conversion of human umbilical cord lining-derived mesenchymal stem cells into hepatocytes. Cell Death Dis 4, e918 (2013).
31. Cheung, T. H. et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11, 2876-2884 (2012).
32. Oneyama, C. et al. MiR-424/503-mediated Rictor upregulation promotes tumor progression. PLoS One 8, e80300 (2013).
33. Berghmans, T. et al. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer 82, 340-345 (2013).
34. Wu, K. et al. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Pathol Oncol Res 19, 739-748 (2013).
35. Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K. & Thompson, E. Epithelialmesenchymal transition. Cancer research 68, 9574-9577 (2008).
36. Stow, J. L. ICAT is a multipotent inhibitor of beta-catenin. Focus on role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. Am J Physiol Cell Physiol 286, C745-746 (2004). (Pubitemid 38543801)
37. Imai, M., Nakamura, T., Akiyama, T. & Horii, A. Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin. Oncol Rep 12, 1099-1103 (2004).
38. Nelson, K., Helmstaedter, V. & Lage, H. The influence of tamoxifen on growth behavior and cell-cell adhesion in OSCC in vitro. Oral oncology 43, 720-727 (2007). (Pubitemid 47061475)
39. Banyard, J. et al. Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Sci Rep 3, 3151 (2013).
40. Wei, Q. et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 94, 52-62 (2014).